Introduction: herbs have been used as medicines since ancient times and it has been observed that human body is well suited to herbal remedies. In the present study, the myocardial salvaging effects of Bacopa monnieri (L) Pennell (Scrophulariaceae) (Bm), a medicinal herb was evaluated in diabetes mellitus.
INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder charac terized by hyperglycemia, caused by insulin deficiency, often combined with insulin resistance. 1 Oxidative stress due to increased production of free radicals and compromised antioxidant defense mechanisms is known to play a signi ficant role in the pathogenesis of diabetes mellitus.
2
Diabetes mellitus is an independent risk factor for cardio vascular disease and is associated with increased suscepti bility to cardiovascular complications. 3 The majo rity of diabetesrelated deaths arise from cardiovascular compli cations, such as myocardial infarction, stroke and peripheral vascular disease. 4 herbs have been used as medicines since ancient times and it has been observed that human body is well suited to herbal remedies. 5 Therefore, the search for an ideal anti diabetic drug has been extended to medicinal herbs with anti diabetic as well other beneficial effects that may be useful to address the various macrovascular and microvascular complications of diabetes mellitus. These herbs if found effective, may be used as adjuncts to modern conventional medicines. Bacopa monniera (Bm), is commonly known as brahmi in Ayurveda, the Indian system of medicine. It has gained worldwide recognition as a memory booster and is used for the treatment of epilepsy and bronchial asthma. 6 The whole plant is therapeutically used and the active ingredients bacosides are mainly responsible for its antioxidant, immunomodulatory and adaptogenic properties. 7, 8 The present study was undertaken to evaluate the cardioprotective acti vity of Bm in the streptozotocin (STZ) model of diabetes mellitus. Further, following STZ induced injury, the safety profile of the medicinal herb was evaluated by studying the histopathological architecture of the liver, kidney, heart and pancreas.
MATERIAlS AND METHODS

Experimental Animals
Adult The animals were assigned to the following experimental groups. There were ten animals in each group.
Group 1: Sham Group-Sham control
Experimental rats were administered 0.9% normal saline orally once a day for 21 days.
Group 2: Streptozotocin Group-STZ control
The rats of this group were administered 0.9% normal saline orally once a day for 21 days. Diabetes was induced to all the rats of this group by a single dose of STZ (65 mg/kg) intraperitoneally on day 0.
Group 3: Treated Group-Bm-75
Bacopa monniera 75 mg/kg body weight was orally fed once in a day to healthy experimental animals for 21 days. On day 0, diabetes induced to experimental rats by a single dose of STZ (65 mg/kg, IP).
Pilot Study
Dose Selection Study for Bacopa monniera
Previous studies from our laboratory shows that a dose of 75 mg/kg of Bm treatment significantly prevented leakage of myocardial enzyme CPK and preserved the myofiber architecture as compared to the ISP induced myocardial necrosis group. hence, Bm (75 mg/kg) dose was selected for further evaluation of its cardioprotective effects in the presence of diabetes mellitus. 9 
Streptozotocin Induced Diabetes Mellitus
STZ is a chemical agent that is specifically cytotoxic to beta cells of the pancreas. Diabetes was induced by a single STZ injection (65 mg/kg body wt, i.p. dissolved in 0.01 M citrate buffer, ph 4.5). Serum glucose was estimated (fasting blood sugar > 200 mg/dl) periodically (day 0, 3, 7, 14, 21) from the tail vein to confirm the status of diabetes mellitus.
PARAMETERS EVAlUATED IN THE PRESENT STUDY
Estimation of Biochemical Parameters
Blood glucose estimation was done on zero, 3rd, 7th, 14th and 21st day after administrating STZ (65 mg/kg, intraperitoneally) to experimental rats using One Touch Basic Blood Glucose Monitor (Omnitest). The rat blood samples were collected from retroorbital vein on the 22nd day. Serum was separated by centrifugation at the speed of 300 rpm for 15 minutes for the estimation of creatine phosphokinase (CPK) and CPKMB. CPKMB activity was estimated by the method. 10 Average body weight (gm/day) was recorded every week and the change in body weight was calculated after 21 days feeding. At the same time, mortality if any during the 21 days of oral administration of the respective drugs was also monitored.
Histopathological Studies
Myocardial, hepatic, renal and pancreatic tissue: at the end of the experiment on the 22nd day the animals were sacrificed. The myocardium, pancreas, liver and kidney were immediately fixed in 10% buffered neutral formalin solution.
The tissues was carefully embedded in molten paraffin with the help of metallic blocks, covered with flexible plastic molds and kept under freezing plates to allow the paraffin to solidify. Cross sections (5 µm thick) of the fixed tissues were cut. These sections were stained with hematoxylin and eosin and visualized under light microscope to study the light microscopic architecture of the myocardium, pancreas, liver and kidney. The investigators performing the histological evaluation were blind to biochemical and hemodynamic results and to treatment allocation.
RESUlTS
Fasting Blood Glucose (FBS) levels
The FBS levels in rats of different experimental groups are depicted in Graph 1. Blood glucose levels in sham group rats were found to 80 ± 6.9, 78.1 ± 6.7, 79. 
CPK Activity
In the sham group, the basal levels of CPK were found to be 1779.85 ± 57.57 IU. Following STZ challenge, in the control group rats, CPK was found to be 3483.61 ± 185.4 IU. Treatment with Bm (75 mg kg), prevented this significant rise in CPK values. Values were reduced to 2800.95 ± 164.7 IU.
CPK-MB Activity
In the sham group, a basal level of CPKMB was found to be 158.4 ± 6.9 IU which increased to 245. 
HISTOPATHOlOGICAl ASSESSMENT
Heart histopathological assessment of the sham group rat hearts revealed the noninfarcted architecture of the myocardium (Fig. 1A) . In contrast, rats subjected to STZ injury, demons t rated marked edema, confluent areas of myonecrosis, separation of myofibrils, congested blood vessels and mild inflammation as compared to the sham group (Fig. 1B) . In the Bm treatment group rats, occasional focal myofiber loss, necrosis, edema and inflammation was observed. However, the degree of edema, inflammation and necrosis was less as compared to the STZ control group (Fig. 1C) .
Pancreas
The pancreas of the sham group were characterized by an organized pattern and showed normal architecture of the islets of Langerhans and the beta cells ( Fig. 2A) . In contrast, in the STZ control group damaged islets of Langerhans and the beta cells with loss of few nucleus and cytoplasm was observed (Fig. 2B ). In the Bm treatment group, few nuclear changes were observed though less compared to STZcontrol group (Fig. 2C ). Figs 1A to C: (A) The sham group revealed the noninfarcted architecture of the myocardium, (B) contrastively, on histological evaluation, rats' hearts subjected to injury demonstrated marked edema, confluent areas of myonecrosis, separation of myofibrils, congested blood vessels and mild inflammation as compared to the sham group, (C) in the Bm treatment group rats, occasional focal myofiber loss, necrosis, edema and inflammation were observed. However, the degree of edema, inflammation and necrosis was less as compared to the control group liver histopathological assessment of liver in sham group showed the normal architecture of central veins, periportal veins and hepatocytes (Fig. 3A) . In contrast to the sham group, the STZ control group showed degeneration and scattered necrotic cells, multifocal mild degree portal lymphocytic infiltration, swollen cytoplasmic hydropic and microvescicular vacuoles (Fig. 3B) . however, treatment with Bm decreased the peri portal inflammation and hepatocytes granular degeneration in diabetic liver as compared to STZ control group. Also no significant congestion in central veins was observed (Fig. 3C ).
Kidney
histopathology of kidney in sham group showed the normal structure of the kidneys. There was absence of congestion of glomerular blood vessels, tubular necrosis, inflammation, cloudy degeneration (Fig. 4A) . In contrast, on histological evaluation, rat's kidney of the STZ control group showed congestion of glomerular blood vessels, tubular necrosis, inflammation and cloudy degeneration as compared to the sham group (Fig. 4B ). The treatment with Bm showed the congestion of glomerular blood vessels, tubular necrosis, inflammation, cloudy degeneration but it was less as compared to the STZ control group (Fig. 4C) .
DISCUSSION
Diabetes mellitus, a metabolic disorder, is characterized by hyperglycemia, altered metabolism of lipids, carbohydrates and proteins with an increased risk of complication of vascular diseases. 4 Type 2 diabetes mellitus is an independent risk factor associated with increased susceptibility to cardio vascular complications, such as ischemic heart disease, myo cardial infarction, stroke and peripheral vascular disease.
11,12
A multifactorial approach for the management of diabetes mellitus addressing its microvascular and macro vascular complications is the need of the hour. There is a large subset of diabetic patients with underlying cardio vascular morbidity. 4 Therefore an antidiabetic drug with additional therapeutic benefits against cardiovascular complications may be beneficial in this group of diabetic patients.
Medicinal plants have been observed to possess nume rous activities such as hypolipidemic, antiplatelet, antithrom botic, cardioprotective, anticoagulant and hypoglycemic Figs 4A to C: (A) Sham group showed that normal structure of the kidneys. There was no congestion of glomerular blood vessels, tubular necrosis, inflammation, cloudy degeneration, (B) contrastively, on histological evaluation, rats kidney of the STZ control group showed congestion of glomerular blood vessels, tubular necrosis, inflammation and cloudy degeneration as compared to the sham group and (C) the treatment with Bm showed the congestion of glomerular blood vessels, tubular necrosis, inflammation, cloudy degeneration but it was less as compared to the STZ control group activities with regard to addressing the macrovascular and microvascular complications of diabetes mellitus. 9 Thus, the use of plant derived agents represents an important and novel therapeutic target and strategy for the treatment of diabetes with coexisting complications. With this point of view, the study was designed. STZ is a chemical agent that is specifically cytotoxic to betacells of the pancreas. STZ induces partial destruction of beta cells within 24 hours, thereby triggering an inflammatory process leading to macrophage and subsequent lympho cyte infiltration, which is followed by the onset of insulin deficiency results in hyperglycemia rather than insulin resistance. Several studies have demonstrated that STZ (65 mg/kg) induces diabetes mellitus in experimental rats. 13 The present study results concur with the previous studies by various authors.
14 Diabetes was induced by a single intraperitoneal STZ injection (65 mg/kg body wt). Following STZ injection, a raised fasting blood glucose levels were observed 72 hours after the injection and maintained throughout the experimental duration; confirming the presence of diabetes in the STZ control group. In the Bm (75 mg/kg) treated group, a significant hypoglycemic activity as indicated by a decline in the fasting blood glucose levels was seen as compared to the STZ control group. A negative correlation between rise in fasting blood sugar and gain in body weight was observed in the experimental groups. Diabetes also induced adverse cardiovascular changes in the rats as indicated by an elevated serum CPK activity of STZ control rats. The leakage of CPK from the myocardium tissue with concomitant rise in the plasma is considered as a marker of myocardial injury. 15, 16 Leakage of this enzyme is a strong evidence for loss of sarcolemmal integrity due to STZ induced injury to the myocardial cells. In the STZ control group, a significant elevation in the serum CPK, CPK-MB and histopathological assessment of the myocardium confirmed the myocardial injury.
The antihyperglycemic activity of Bm was observed in the STZ model of diabetes mellitus. In addition to its bene ficial effect on serum blood glucose, the cardioprotective effect of Bm was also evaluated in the present study. However, this is the first study further exploring the cardioprotective effects of Bm in the presence of diabetes mellitus. In the present study, Bm (75 mg/kg) treatment significantly preserved the myocardial enzyme CPK and myofiber architecture as compared to the STZ control group. Biochemical and histopathological evaluation confirmed the myocardial salvaging effects of Bm (75 mg/kg) in the presence of diabetes mellitus. In addition to the favorable effect of Bm on the myocardialarchitecture, Bm treatment also preserved the histopathological structure of the hepatic, renal and pancreatic tissue. Therefore, Bm (75 mg/kg) is a safe efficacious cardioprotective medicinal herb.
Nature has been a source of medicines for thousands of years and plantderived products continue to play an essential role in the primary healthcare of the world's population. 20 Bm, a medicinal herb traditionally used have been evaluated scientifically in the present study with an aim to define the role of these agents in limiting the deleterious effects of STZ induced diabetes mellitus. The study provides preliminary scientific data to further evaluate Bm as a promising antidiabetic herb with potential cardiovascular benefits.
CONClUSION
Bm demonstrated significant myocardial salvaging effects in the presence of diabetes mellitus. histopathological assess ment of the myocardium and CPK levels confirmed the cardio protective effects of Bm (75 mg/kg) in the STZ model of diabetes mellitus. In addition, Bm (75 mg/kg) pretreatment was safe to the vital organs as it preserved the histopatho logical structure of the hepatic, renal and pancreatic tissues.
